41203-22-9 Usage
Description
1,4,8,11-Tetramethyl-1,4,8,11-tetraazacyclotetradecane, also known as a macrocyclic chelating agent, is a white to slightly yellow crystalline compound with low melting properties. It is characterized by its ability to form strong bonds with a wide range of metal ions, making it a versatile ligand in coordination chemistry and a useful component in the synthesis of crown ethers.
Uses
Used in Coordination Chemistry:
1,4,8,11-Tetramethyl-1,4,8,11-tetraazacyclotetradecane is used as a macrocyclic chelating agent for [forming stable complexes with metal ions] in coordination chemistry. Its strong binding affinity to various metal ions allows for the creation of stable complexes, which are essential in numerous chemical reactions and applications.
Used in Crown Ether Synthesis:
1,4,8,11-Tetramethyl-1,4,8,11-tetraazacyclotetradecane is used as a ligand for [binding to metal ions and forming crown ethers] in the synthesis of crown ethers. Crown ethers are a class of compounds with a central hole that can selectively bind to specific metal ions, making them valuable in various chemical processes and applications.
Used in Analytical Chemistry:
1,4,8,11-Tetramethyl-1,4,8,11-tetraazacyclotetradecane is used as a ligand for [determining metal ion concentrations and speciation] in analytical chemistry. Its ability to form complexes with metal ions allows for the accurate determination of metal ion concentrations and speciation in various samples, which is crucial for understanding their environmental and biological impacts.
Used in Pharmaceutical Industry:
1,4,8,11-Tetramethyl-1,4,8,11-tetraazacyclotetradecane is used as a chelating agent for [improving the solubility and stability of metal-containing drugs] in the pharmaceutical industry. Its strong binding to metal ions can enhance the solubility and stability of metal-containing drugs, potentially improving their efficacy and reducing side effects.
Used in Environmental Applications:
1,4,8,11-Tetramethyl-1,4,8,11-tetraazacyclotetradecane is used as a chelating agent for [removing toxic metal ions from contaminated environments] in environmental applications. Its ability to form stable complexes with metal ions can help in the removal of toxic metals from contaminated water, soil, and air, contributing to environmental remediation efforts.
Check Digit Verification of cas no
The CAS Registry Mumber 41203-22-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,2,0 and 3 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 41203-22:
(7*4)+(6*1)+(5*2)+(4*0)+(3*3)+(2*2)+(1*2)=59
59 % 10 = 9
So 41203-22-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H32N4/c1-15-7-5-8-17(3)13-14-18(4)10-6-9-16(2)12-11-15/h5-14H2,1-4H3/p+4
41203-22-9Relevant articles and documents
THE APPLICATION OF ULTRASOUND TO N-METHYLATION OF DIAZACORONANDS
Jurczak, Janusz,Ostaszewski, Ryszard
, p. 959 - 960 (1988)
The application of ultrasound to N-methylation of variety of diazacoronands by methyl iodide under phase transfer conditions leads to N,N'-dimethyl diazacoronands in almost quantitative yields.
Composition, synthesis and therapeutic applications of polyamines
-
, (2008/06/13)
This invention relates to a process of synthesis and composition of open chain (ring), closed ring, linear branched and or substituted polyamines, polyamine derived tyrosine phosphatase inhibitors and PPAR partial agonists/partial antagonists via a series of substitution reactions and optimizing the bioavailability and biological activities of the compounds. Polyamines prevent the toxicty of neutoxins and diabetogenic toxins including paraquat, methyphenyl pyridine radical, rotenone, diazoxide, streptozotocin and alloxan. These polyamines can be to treat neurological, cardiovascular, endocrine acquired and inherited mitochondrial DNA damage diseases and other disorders in mammalian subjects, and more specifically to the therapy of Parkinson's disease, Alzheimer's disease, Lou Gehrig's disease, Binswanger's disease, Olivopontine Cerebellar Degeneration, Lewy Body disease, Diabetes, Stroke, Atherosclerosis, Myocardial Ischemia, Cardiomyopathy, Nephropathy, Ischemia, Glaucoma, Presbycussis, Cancer, Osteoporosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis and as Antidotes to Toxin Exposure.
Method for preparing alkoxyamines from nitroxides
-
, (2008/06/13)
The invention relates to a process for preparing alkoxyamines. This process consists in mixing, in an organic solvent, a metal salt, a ligand for the metal, a halocarbon compound ZX and a nitroxide, in keeping the reaction medium stirring at a temperature of between 20° C. and 90° C. until the nitroxide has disappeared, in recovering the organic phase, in washing it with water and then in isolating the alkoxyamine by evaporating the organic solvent under reduced pressure.
